Who’s Going to the Festival of Genomics London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
243 organizations and 308 speakers at the Festival of Genomics & Biodata (FoG) London 2027, an ~8,300-person, evenly mixed academic, clinical and industry meeting of UK and European genomics researchers, NHS genomics teams and biotech. As of Oct 29, 2026.
| Organization | FoG London 2027 Attendance |
|---|---|
University of Oxford Oxford, UK | |
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research. | Talk Wed Jan 27 11:30–12:00 Why Do We Sleep? Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health. Population & social genomics Talk Wed Jan 27 12:30–13:00 Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent. Talk Wed Jan 27 14:30–15:00 Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles. Talk Wed Jan 27 14:30–15:00 Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread. Talk Wed Jan 27 16:30–17:00 Accelerating the Development of Therapies for Rare Genetic Disease How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases. Talk Wed Jan 27 16:30–17:00 The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics. Talk Wed Jan 27 16:30–17:00 The Body Clock in Your Blood: Circadian Signals in Omics Research How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies. Talk Wed Jan 27 17:30–18:00 Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines. Talk Thu Jan 28 11:30–12:00 Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures. Talk Thu Jan 28 12:30–13:00 Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating. Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Talk Thu Jan 28 14:10–14:40 Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them. Talk Thu Jan 28 14:10–14:40 Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes. Talk Thu Jan 28 14:10–14:40 Why Endometriosis Is Not One Disease: Insights from Genetics How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets. Workshop Thu Jan 28 14:10–15:40 Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation Multi-omics & proteomics Talk Thu Jan 28 14:40–15:10 Talk Thu Jan 28 15:10–15:40 Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Talk Thu Jan 28 16:10–16:40 Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it. Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working. Talk Thu Jan 28 16:40–17:10 Leveraging Big Data to Inform Cardiovascular Precision Medicine How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment. |
UCL London, UK | |
Multidisciplinary London research university with faculties of medical, life, brain and population health sciences, including the Great Ormond Street Institute of Child Health. | Talk Wed Jan 27 11:30–12:00 What Do We Need to Get More Advanced Therapies to Patients? How regulatory changes in the US, UK and EU, plus practical rollout models, could bring more advanced therapies to patients. Talk Wed Jan 27 12:30–13:00 Quantitative Proteomics to Unravel Signaling in Rare Cells How mapping protein phosphorylation in just hundreds of cells reveals dormant, drug-resistant glioblastoma cells and leftover disease in acute myeloid leukaemia. Talk Wed Jan 27 14:30–15:00 Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting How large human brain RNA datasets link disease-associated genetic variants to genes and mechanisms in Lewy body disorders and related neurodegenerative diseases. Talk Wed Jan 27 15:30–16:00 Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion How mapping cells in place across primary tumours and their metastases reveals the earliest steps of cancer spread and immune escape. Talk Wed Jan 27 15:30–16:00 Why Does the Food Environment Affect Us Differently? What it means to call obesity genetic, how genes and food surroundings interact to shape weight, and what a twin study shows. Population & social genomics Talk Wed Jan 27 16:30–17:00 Personalised Surveillance in Ovarian Cancer: Does It Work? Whether tracking a blood tumour marker over time helps women at high genetic risk of ovarian cancer who are awaiting preventive surgery. Talk Wed Jan 27 16:30–17:00 Why Do We Age So DIfferently? Why people with similar genes and lifestyles age at different rates, and what genetically identical organisms reveal about chance in ageing. Population & social genomics Talk Thu Jan 28 10:30–11:00 Who Do We Think We Are? What the Last Decade of Genomics Has Revealed About Us What ancient DNA has revealed about human migration and ancestry, and what genetics can and cannot say about race and identity. Population & social genomics Talk Thu Jan 28 11:30–12:00 Ageing as a Modifiable Process: From Lifestyle to Therapeutic Intervention How exercise, sleep, diet and social life shape ageing, and whether existing drugs could target ageing biology to delay disease. Talk Thu Jan 28 11:30–12:00 Talk Thu Jan 28 12:30–13:00 Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy Why pregnant women were long excluded from clinical trials, how pregnancy research can now run safely, and what fetal gene therapy could offer. Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics Talk Thu Jan 28 16:10–16:40 25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential How gene and cell therapies are moving from experiments toward potential cures for inherited blood diseases and cancer, and what blocks wider access. Talk Thu Jan 28 16:10–16:40 Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction How to judge whether polygenic risk scores and blood protein markers really help with screening, risk grouping and predicting individual disease risk. Talk Thu Jan 28 16:40–17:10 From Research to Reality: Ensuring Women Benefit from Innovation How to design women's health tests and technologies that work for all women, and who risks being left behind by them. |
University of Cambridge Cambridge, UK | |
Collegiate research university in Cambridge, England, whose School of Clinical Medicine sits on the Cambridge Biomedical Campus beside Addenbrooke's Hospital. | Talk Wed Jan 27 11:30–12:00 Integrating Spatial Multi-Omics: From Technology Development to Biological Discovery How combining RNA and protein maps of tissue shows how ovarian tumour cells interact with immune cells across body sites and tumour types. Talk Wed Jan 27 11:30–12:00 Preeclampsia and Fetal Growth Restriction: From Prediction to Prevention How tracking proteins, RNA and metabolites through pregnancy could flag placental problems like preeclampsia and fetal growth restriction before symptoms appear. Talk Wed Jan 27 15:30–16:00 Tracking the Emergence and Spread of Antimicrobial Resistance Through Bacterial Genomics How building family trees from bacterial genomes dates the rise of drug-resistant strains, measures policy effects and traces hospital outbreaks. Talk Wed Jan 27 16:30–17:00 Beyond Single-Gene Testing: Using Polygenic Risk to Guide Precision Treatment How a person's overall genetic profile, not single genes, could show who benefits most from diabetes and high blood pressure treatments. Talk Wed Jan 27 17:30–18:00 From Stem Cell States to Stem Cell Flux: Navigating Cellular Landscapes Using scRNA Seq How single-cell RNA sequencing and computer models reconstruct the paths stem cells take as they change and choose their fates. Talk Wed Jan 27 17:30–18:00 Using AI and Spatial Multiomics to Decode Tumour Evolution and Identify High-Risk Cancer Why cancers with similar genetic drivers behave so differently, and how AI applied to maps of tumour tissue could flag aggressive cancers earlier. Talk Thu Jan 28 08:45–09:15 Why Are We Hungry? What Genomics Is Revealing About Appetite and Obesity What rare genetic cases, population studies and cell-by-cell brain maps reveal about the biology of appetite and obesity. Single-cell genomicsPopulation & social genomics Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics Talk Thu Jan 28 15:10–15:40 Beyond Polygenic Risk Scores: Integrating Genetics and Multi-Omic Data for Personalised Risk Stratification and Earlier Screening How large international collaborations are improving cardiovascular risk prediction, and the evidence tying overweight and obesity to higher death rates. Talk Thu Jan 28 16:40–17:10 Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA How a method that reads very scarce tumour DNA in the blood tracks lung cancer's evolving cell populations and hints at hidden immunotherapy resistance. |
Find buyers from organizations at FoG London 2027
Tell us what you sell and we’ll find the people at these organizations most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where is FoG London 2027?
The Festival of Genomics & Biodata London 2027 runs January 27–28, 2027, at ExCeL London in London, UK.
Where is the FoG London 2027 program?
This guide lists every organization on the FoG London 2027 program with its sessions; the full program is on the official website.
How do I register for FoG London 2027?
Fees and registration are on the organizer's registration page.
What conference is this?
The Festival of Genomics & Biodata London is a two-day genomics meeting run by Front Line Genomics, held January 27–28, 2027 at ExCeL London. It brings UK and European genomics researchers, NHS genomic medicine and laboratory teams, biobanks and national programmes together with the sequencing, lab, data and diagnostics companies that serve them, across stages on genomic medicine, cancer diagnostics, AI, biodata, single-cell, spatial, multi-omics, epigenetics, pharmacogenomics, women’s and children’s health, advanced therapies, microbes and plant genomics.
What is in this guide?
Every organization we can place at FoG London 2027: 308 speakers from the public agenda and speaker list (256 sessions) rolled up to their companies and institutions, plus the 112 sponsors and exhibitors from the public directory with their stand numbers — 243 organizations in one list. Speakers appear as job titles, never by name.
How are organizations typed?
By the role an organization plays in genomics: drug developers, then the companies around them — sequencing and genomics platforms, reagents and lab equipment, sequencing services and CROs, diagnostics, software, AI and data, and other services — and universities and institutes, the NHS and hospitals, and government bodies, biobanks and non-profits. The topic filters come from the stage a session is on, and for the main stage, the lounge and the workshops from the organizer’s own track tags or the session’s title and description.
How current is it?
Pulled from the public agenda, speaker list and sponsor and exhibitor directory on October 29, 2026. 215 of the agenda’s sessions carried a description, and some sponsored slots had no details yet; the exhibition’s opening hours are not published.
Browse FoG London 2027 by
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Organizations with their own page
155 organizations — every exhibitor and every organization with 2 or more presentations.
- Abcam
- Agena Bioscience
- Agilent
- Alida Biosciences
- All Wales Medical Genomics Service
- Altheome
- Amazon Web Services
- Ardigen
- Association of Genetic Nurses and Counsellors
- AstraZeneca
- Avantor
- BaseClear
- Beckman Coulter
- Bio Molecular Systems
- Bio-Rad
- Bio-Techne
- biomodal
- Bioptimus
- BIOS IT
- BRAND
- Calibre Scientific
- Caltag Medsystems
- Cambridge Bioscience
- Cambridge University Hospitals NHS Foundation Trust
- Cancer Research UK Manchester Institute
- CeGaT
- Cell and Gene Therapy Catapult
- City St George's, University of London
- Congenica
- Cytiva
- Data Intuitive
- Devyser
- DNA Genotek
- DNAnexus
- Earlham Institute
- Edge Health
- Element Biosciences
- ELIXIR
- Eurofins
- Fios Genomics
- Formulatrix
- Francis Crick Institute
- Genetic Alliance UK
- GENEWIZ
- Genomics
- Genomics England
- Genomics Partnership Wales
- GenQA
- German Cancer Research Center (DKFZ)
- Great Ormond Street Hospital
- GSK
- Hamilton
- Health Data Research Service
- Health Data Research UK
- Illumina
- Imperial College London
- INTEGRA Biosciences
- Integrated DNA Technologies
- Invivoscribe
- Isohelix
- King's College London
- Leiden University Medical Center
- Lifebit
- LVL technologies
- M20 Genomics
- Macrogen
- MHRA
- Microzone
- Miltenyi Biotec
- Mission Bio
- Moleculent
- MRC Holland
- Médecins Sans Frontières
- n6
- NBS Scientific
- New England Biolabs
- NHS Cancer Alliance
- NHS England
- Nightingale Health
- NIHR BioResource
- NimaGen
- Nocteva
- Nonacus
- North West Genomic Medicine Service Alliance
- Novo Nordisk
- Novogene
- Octapharma
- Omega Bio-tek
- Our Future Health
- Oxford Gene Technology
- Oxford Nanopore Technologies
- PacBio
- Panome Bio
- Parse Biosciences
- PCR Biosystems
- PHCbi
- PhiTech
- Plasmidsaurus
- Population Research UK
- Promega
- Public Health Wales
- QIAGEN
- Quantabio
- Queen Mary University of London
- Queen's University Belfast
- RAN Biotechnologies
- Rancho BioSciences
- Relation Therapeutics
- Revolune
- Roche
- Rothamsted Research
- Saphetor
- SeekGene
- Seqera
- Single Cell Discoveries
- Singleron
- SOPHiA GENETICS
- Source Genomics
- SPT Labtech
- St George's University Hospitals NHS Foundation Trust
- Starlab
- Stellaromics
- Steribar
- The Hyve
- The Institute of Cancer Research
- The Royal Marsden NHS Foundation Trust
- Thistle Scientific
- TRUPCR
- TTP
- Twist Bioscience
- UCB
- UCL
- UK Biobank
- UK Longitudinal Linkage Collaboration
- UK NEQAS
- Ultima Genomics
- Understanding Society
- Unique
- University of Aberdeen
- University of Birmingham
- University of Bristol
- University of Cambridge
- University of Edinburgh
- University of Exeter
- University of Glasgow
- University of Manchester
- University of Nottingham
- University of Oxford
- University of Sheffield
- University of Surrey
- Watchmaker Genomics
- Wellcome Genome Campus
- Wellcome Sanger Institute
- Yeasen
- Yourgene Health
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction